Details

DSEN Abstract: SGLT2 Inhibitors and the Risk of Diabetic Ketoacidosis:A study conducted by the Canadian Network for Observational Drug Effect Studies (CNODES) - CIHR

Metadata and links for an archived snapshot.

Source
Canadian Institutes of Health Research
Date
May 1, 2026 · edition #8
Timestamp
2026-05-01T09:47:36.197Z
Language
en
ID
1364806
Status
200
Type
text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots

Archived page preview